Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy
Eptiflo 0.75mg/ml Infusion 1
Eptiflo 0.75mg/ml Infusion 2
Not for sale, We do not facilitate sale of this product in this state

Eptiflo 0.75mg/ml Infusion

Eptifibatide (0.75mg/ml)
Genuine
Authenticity Assured
Prescription
required
Cold stored
Stored between 2-8°C

Product Summary :

Eptiflo 0.75mg/ml Infusion is an antiplatelet medicine used to treat unstable angina, prevention of blood clots, and prevention of heart attacks. It blocks a protein on platelets, preventing them from sticking together and forming blood clots. It is given into a vein under medical supervision. Bleeding and low platelet counts may happen, so regular monitoring is required.


Written By Dr. Subita Alagh, BDS,
Reviewed By Dr. Rajeev Sharma, MBA, MBBS,
Last updated on 04 Nov 2026 | 03:19 PM (IST)
₹7700 MRP ₹8371.428% off 
We do not facilitate the sale of this product
(Inclusive of applicable taxes)
 
 
0
footer-icon

Save more with additional offers

offer icon
Flat ₹50 cashback. T&C Apply*
Flat ₹50 cashback. T&C Apply*
chevron icon
offer icon
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).
chevron icon
offer icon
Get up to ₹150 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹150 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
chevron icon
offer icon
Flat ₹50 cashback. T&C Apply*
Flat ₹50 cashback. T&C Apply*
chevron icon
offer icon
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).
chevron icon
offer icon
Get up to ₹150 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹150 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
chevron icon
offer icon
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
chevron icon

General Information

Contains

Eptifibatide (0.75mg/ml)

Marketer

Sun Pharmaceutical Industries Ltd

Storage

Store in a refrigerator (2 - 8°C). Do not freeze.
The content is shown in English
Eptiflo 0.75mg/ml Infusion 1
Eptiflo 0.75mg/ml Infusion 2

Product introduction

Eptiflo 0.75mg/ml Infusion is a blood thinner which prevents formation of harmful blood clots. It is used in the treatment of a heart attack and also prevents the clotting of blood in the heart during an angioplasty (procedure to improve blood flow to the heart).

Eptiflo 0.75mg/ml Infusion is given by a doctor or nurse through a vein (intravenous injection or infusion) in a hospital. Your doctor will decide the dose and duration based on your condition and kidney function. It may be given along with other medicines, such as aspirin or heparin, to reduce the risk of blood clots.


It may increase the risk of bleeding and may also reduce the number of platelets in your blood. Inform your doctor immediately if you notice unusual bruising, bleeding from the gums or nose, blood in your urine or stools, black stools, or vomiting of blood. Your doctor will monitor your blood counts and other tests during treatment.


Before receiving Eptiflo 0.75mg/ml Infusion, tell your doctor if you have a history of bleeding, stroke, recent surgery, high blood pressure, or kidney problems. Also inform your doctor about all the medicines you take, especially blood thinners, antiplatelet medicines and painkillers such as ibuprofen. If you are pregnant or breastfeeding, discuss this with your doctor before treatment.

Uses of Eptiflo Infusion

Benefits of Eptiflo Infusion

Prevention of Heart attack
It prevents blood from clotting inside the veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). Follow your doctor’s instructions carefully and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
Prevention of Blood clots
Eptiflo 0.75mg/ml Infusion prevents new blood clots from forming and prevents the existing ones from getting bigger. It works by blocking a substance in the body which is involved in blood clotting. Thus it helps your blood flow smoothly throughout the body. This can help reduce damage caused by clots in your lungs (pulmonary embolism), brain (stroke), heart (heart attack) or other blood vessels (thrombosis).

Side effects of Eptiflo Infusion

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Eptiflo
  • Bleeding

How to use Eptiflo Infusion

Your doctor or nurse will give you this medicine. Kindly do not self-administer.

How Eptiflo Infusion works

Eptiflo 0.75mg/ml Infusion is an antiplatelet medication. It works by preventing the platelets from sticking together, thereby decreasing the formation of harmful blood clots.

Dosage

Eptiflo 0.75mg/ml Infusion is given into a vein as an injection followed by a continuous infusion, depending on the condition being treated. The dose is calculated according to body weight and kidney function. Your doctor will decide the dose and duration of treatment and monitor you during administration.

All substitutes for Eptiflo 0.75mg/ml Infusion

For information purposes only. Consult a doctor before taking any medicine.

Quick tips

  • Eptiflo 0.75mg/ml Infusion is given by a doctor or nurse through a vein, usually as an injection followed by an infusion.
  • This medicine increases the risk of bleeding. Avoid unnecessary injuries and inform your doctor if you notice unusual bruising or bleeding.
  • Tell your doctor immediately if you notice blood in your urine or stools, black stools, vomiting of blood, or bleeding that does not stop.
  • Inform your doctor about all medicines you are taking, especially blood thinners, antiplatelet medicines and painkillers such as ibuprofen.
  • Your doctor may monitor your platelet count, kidney function and other blood tests during treatment.

Safety advice

Alcohol

Alcohol

CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Eptiflo 0.75mg/ml Infusion. Please consult your doctor.
Pregnancy

Pregnancy

CONSULT YOUR DOCTOR
Information regarding the use of Eptiflo 0.75mg/ml Infusion during pregnancy is not available. Please consult your doctor.
Breast feeding

Breast feeding

SAFE IF PRESCRIBED
Available human data suggest that the drug does not pass into breast milk in clinically significant amounts and is unlikely to harm the infant.
Driving

Driving

NOT RELEVANT
Not relevant, as Eptiflo 0.75mg/ml Infusion is intended for use in hospitalized patients.
Kidney

Kidney

CAUTION
Eptiflo 0.75mg/ml Infusion should be used with caution in patients with kidney disease. Dose adjustment may be needed.
Use of Eptiflo 0.75mg/ml Infusion is not recommended in patients with severe kidney disease.
Liver

Liver

CONSULT YOUR DOCTOR
There is limited data available on the use of Eptiflo 0.75mg/ml Infusion in patients with liver disease.
Use of Eptiflo 0.75mg/ml Infusion is not recommended in patients with severe liver disease.

Interaction with drugs

Taking Eptiflo with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Severe

Apixaban (Oral Route)

Do not consume Apixaban with Eptifibatide. If concurrent use is essential, watch out for bleeding and consult your doctor immediately.
Moderate

Ticagrelor (Oral Route)

Inform your doctor if you notice any signs of bleeding (bruising, bleeding gums, blood in stool/vomit/urine).
Moderate

Rivaroxaban (Oral Route)

Talk to your doctor if you notice any unusual symptoms.
Moderate

Dabigatran Etexilate (Oral Route)

If concurrent use is essential, watch out for bleeding and consult your doctor immediately.
Moderate

Desvenlafaxine (Oral Route)

If concurrent use is essential, watch out for bleeding and consult with your doctor immediately.

Frequently asked questions

Eptiflo 0.75mg/ml Infusion is used to treat acute coronary syndrome, including unstable angina, and in patients undergoing angioplasty (a procedure to open narrowed or blocked heart arteries). It helps prevent platelets from clumping together and forming blood clots.
Eptiflo 0.75mg/ml Infusion is administered directly into a vein by a trained healthcare professional usually as an injection followed by a continuous infusion. It is generally given in a hospital under medical supervision.
Yes. Eptiflo 0.75mg/ml Infusion reduces the ability of platelets to form clots and can increase the risk of bleeding. Inform your doctor immediately if you notice unusual bruising, nose or gum bleeding, blood in your urine or stools, or vomiting of blood.
Yes. Eptiflo 0.75mg/ml Infusion may cause a decrease in the number of platelets in the blood. Your doctor may monitor your platelet count during treatment.
Yes. Eptiflo 0.75mg/ml Infusion may be given with medicines such as aspirin or heparin in certain heart conditions or during angioplasty. However, combining these medicines can increase the risk of bleeding, so they should only be used under close medical supervision.
Do not take painkillers such as ibuprofen, naproxen or aspirin on your own while receiving Eptiflo 0.75mg/ml Infusion. Some medicines can increase the risk of bleeding. Tell your doctor about all medicines you take before treatment.
No. Eptiflo 0.75mg/ml Infusion does not directly dissolve an existing blood clot. It prevents platelets from sticking together and forming new clots or making existing platelet-rich clots larger.

Fact Box

Chemical Class

Peptides

Habit Forming

No

Therapeutic Class

BLOOD RELATED

Action Class

Glycoprotein IIb/IIIa Inhibitors

References

  1. Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 871.
  2. Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 355-56.
  3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 485-46.
  4. Eptifibatide. Ferentino, Italy: Patheon Italia S.p.A.; 1998 [revised Mar. 2013]. [Accessed 18 Mar. 2019] (online) Available from:
  5. Central Drugs Standard Control Organisation (CDSCO). Eptifibatide. [Accessed 18 Mar. 2019] (online) Available from:
  6. Eptifibatide [Prescribing information]. solution Avenacy, LLC; 2026. [Accessed 02 Nov 2026]. Available from:
100% genuine products
100% genuine products
Safe & secure payments
Safe & secure payments
No contact delivery
No contact delivery
Fully sanitized facilities
Fully sanitized facilities

User feedback

Heart attack
100%
<h3 class=titleMediumExtraBold>Want to know more</h3>

Want to know more

We provide you with authentic, trustworthy and relevant information
<h3 class=titleMediumExtraBold>Have issue with the content</h3>

Have issue with the content

Disclaimer

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Marketer details

Name: Sun Pharmaceutical Industries Ltd
Address: Plot no 107/108,Namli block , Ranipool, East Sikkim 737135 || Khasra No. 1335-1340,Near EPIP- I, Vill - Bhatoli Kalan ,Baddi, Solan, Himachal Pradesh, 173205 || Acme Plaza, Andheri-Kurla Road, Andheri (East), Mumbai, Maharashtra -400059

Vendor Details

Country of origin: India
Why we need a prescription?
Cold chain description image
close sheet